BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Eeden C, Khan L, Osman MS, Cohen Tervaert JW. Natural Killer Cell Dysfunction and Its Role in COVID-19. Int J Mol Sci 2020;21:E6351. [PMID: 32883007 DOI: 10.3390/ijms21176351] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Sasso EM, Muraki K, Eaton-fitch N, Smith P, Lesslar OL, Deed G, Marshall-gradisnik S. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients. Mol Med 2022;28. [DOI: 10.1186/s10020-022-00528-y] [Reference Citation Analysis]
2 van Eeden C, Osman MS, Cohen Tervaert JW. Fatigue in ANCA-associated vasculitis (AAV) and systemic sclerosis (SSc): similarities with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A critical review of the literature. Expert Rev Clin Immunol 2022;:1-22. [PMID: 36045606 DOI: 10.1080/1744666X.2022.2116002] [Reference Citation Analysis]
3 Khare K, Pandey R. Cellular heterogeneity in disease severity and clinical outcome: Granular understanding of immune response is key. Front Immunol 2022;13:973070. [DOI: 10.3389/fimmu.2022.973070] [Reference Citation Analysis]
4 Shirzad M, Nourigorji M, Sajedi A, Ranjbar M, Rasti F, Sourani Z, Moradi M, Mostafa Mir S, Memar MY. Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine. Int Immunopharmacol 2022;111:109161. [PMID: 35998506 DOI: 10.1016/j.intimp.2022.109161] [Reference Citation Analysis]
5 Zeinali T, Faraji N, Joukar F, Khan Mirzaei M, Kafshdar Jalali H, Shenagari M, Mansour-ghanaei F. Gut bacteria, bacteriophages, and probiotics: Tripartite mutualism to quench the SARS-CoV2 storm. Microbial Pathogenesis 2022. [DOI: 10.1016/j.micpath.2022.105704] [Reference Citation Analysis]
6 Dave TV, Nair AG, Joseph J, Freitag SK. Immunopathology of COVID-19 and its implications in the development of rhino-orbital-cerebral mucormycosis: a major review. Orbit 2022;:1-10. [PMID: 35856238 DOI: 10.1080/01676830.2022.2099428] [Reference Citation Analysis]
7 Kudryavtsev IV, Golovkin AS, Totolian AA. T helper cell subsets and related target cells in acute COVID-19. Russian Journal of Infection and Immunity 2022;12:409-26. [DOI: 10.15789/2220-7619-thc-1882] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Boland L, Bitterlich LM, Hogan AE, Ankrum JA, English K. Translating MSC Therapy in the Age of Obesity. Front Immunol 2022;13:943333. [DOI: 10.3389/fimmu.2022.943333] [Reference Citation Analysis]
9 Gutiérrez-bautista JF, Martinez-chamorro A, Rodriguez-nicolas A, Rosales-castillo A, Jiménez P, Anderson P, López-ruz MÁ, López-nevot MÁ, Ruiz-cabello F. Major Histocompatibility Complex Class I Chain-Related α (MICA) STR Polymorphisms in COVID-19 Patients. IJMS 2022;23:6979. [DOI: 10.3390/ijms23136979] [Reference Citation Analysis]
10 Zheng J, Miao J, Guo R, Guo J, Fan Z, Kong X, Gao R, Yang L. Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2. Front Cell Infect Microbiol 2022;12:931061. [DOI: 10.3389/fcimb.2022.931061] [Reference Citation Analysis]
11 Garcinuño S, Gil-Etayo FJ, Mancebo E, López-Nevado M, Lalueza A, Díaz-Simón R, Pleguezuelo DE, Serrano M, Cabrera-Marante O, Allende LM, Paz-Artal E, Serrano A. Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution. Int J Mol Sci 2022;23:6577. [PMID: 35743021 DOI: 10.3390/ijms23126577] [Reference Citation Analysis]
12 Durkee-Shock J, Lazarski CA, Jensen-Wachspress MA, Zhang A, Son A, Kankate VV, Field NE, Webber K, Lang H, Conway SR, Hanley PJ, Bollard CM, Keller MD, Schwartz DM. Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products. Mol Ther Methods Clin Dev 2022;25:439-47. [PMID: 35506060 DOI: 10.1016/j.omtm.2022.04.013] [Reference Citation Analysis]
13 Soleimanian S, Alyasin S, Sepahi N, Ghahramani Z, Kanannejad Z, Yaghobi R, Karimi MH. An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19. Front Immunol 2022;13:884879. [PMID: 35669767 DOI: 10.3389/fimmu.2022.884879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Fadaei Y, Rihan FA, Rajivganthi C, Cai N. Immunokinetic Model for COVID-19 Patients. Complexity 2022;2022:1-13. [DOI: 10.1155/2022/8321848] [Reference Citation Analysis]
15 Fang KY, Liang GN, Zhuang ZQ, Fang YX, Dong YQ, Liang CJ, Chen XY, Guo XG. Screening the hub genes and analyzing the mechanisms in discharged COVID-19 patients retesting positive through bioinformatics analysis. J Clin Lab Anal 2022;:e24495. [PMID: 35657140 DOI: 10.1002/jcla.24495] [Reference Citation Analysis]
16 Mohammed RN, Tamjidifar R, Rahman HS, Adili A, Ghoreishizadeh S, Saeedi H, Thangavelu L, Shomali N, Aslaminabad R, Marofi F, Tahavvori M, Danishna S, Akbari M, Ercan G. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19). Cell Commun Signal 2022;20. [DOI: 10.1186/s12964-022-00856-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Zavvar M, Yahyapoor A, Baghdadi H, Zargaran S, Assadiasl S, Abdolmohammadi K, Hossein Abooei A, Reza Sattarian M, Jalalifarahani M, Zarei N, Farahvash A, Fatahi Y, Deniz G, Zarebavani M, Nicknam MH. COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches. International Immunopharmacology 2022;107:108655. [DOI: 10.1016/j.intimp.2022.108655] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Lee YK, Haam JH, Suh E, Cho SH, Kim YS. A Case-Control Study on the Changes in Natural Killer Cell Activity following Administration of Polyvalent Mechanical Bacterial Lysate in Korean Adults with Recurrent Respiratory Tract Infection. J Clin Med 2022;11:3014. [PMID: 35683402 DOI: 10.3390/jcm11113014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kudryavtsev I, Rubinstein A, Golovkin A, Kalinina O, Vasilyev K, Rudenko L, Isakova-sivak I. Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview. Viruses 2022;14:1082. [DOI: 10.3390/v14051082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
20 Farzad F, Yaghoubi N, Jabbari-Azad F, Mahmoudi M, Mohammadi M. Prognostic Value of Serum MICA Levels as a Marker of Severity in COVID-19 Patients. Immunol Invest 2022;:1-11. [PMID: 35481955 DOI: 10.1080/08820139.2022.2069035] [Reference Citation Analysis]
21 Deng X, Terunuma H, Nieda M. Exploring the Utility of NK Cells in COVID-19. Biomedicines 2022;10:1002. [DOI: 10.3390/biomedicines10051002] [Reference Citation Analysis]
22 López-Cortés A, Guerrero S, Ortiz-Prado E, Yumiceba V, Vera-Guapi A, León Cáceres Á, Simbaña-Rivera K, Gómez-Jaramillo AM, Echeverría-Garcés G, García-Cárdenas JM, Guevara-Ramírez P, Cabrera-Andrade A, Puig San Andrés L, Cevallos-Robalino D, Bautista J, Armendáriz-Castillo I, Pérez-Villa A, Abad-Sojos A, Ramos-Medina MJ, León-Sosa A, Abarca E, Pérez-Meza ÁA, Nieto-Jaramillo K, Jácome AV, Morillo A, Arias-Erazo F, Fuenmayor-González L, Quiñones LA, Kyriakidis NC. Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials. Front Pharmacol 2022;13:833174. [PMID: 35422702 DOI: 10.3389/fphar.2022.833174] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Negm EM. Does mass management of chronic hepatitis C protect the Egyptian population against fulminant coronavirus disease-2019? “Postulating a hypothesis”. Egypt J Bronchol 2022;16. [DOI: 10.1186/s43168-022-00120-2] [Reference Citation Analysis]
24 Saghafi N, Rezaee SA, Momtazi-Borojeni AA, Tavasolian F, Sathyapalan T, Abdollahi E, Sahebkar A. The therapeutic potential of regulatory T cells in reducing cardiovascular complications in patients with severe COVID-19. Life Sci 2022;:120392. [PMID: 35149115 DOI: 10.1016/j.lfs.2022.120392] [Reference Citation Analysis]
25 Du Y, Hertoghs N, Duffy FJ, Carnes J, McDermott SM, Neal ML, Schwedhelm KV, McElrath MJ, De Rosa SC, Aitchison JD, Stuart KD. Systems analysis of immune responses to attenuated P. falciparum malaria sporozoite vaccination reveals excessive inflammatory signatures correlating with impaired immunity. PLoS Pathog 2022;18:e1010282. [PMID: 35108339 DOI: 10.1371/journal.ppat.1010282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Li S, Zhao F, Ye J, Li K, Wang Q, Du Z, Yue Q, Wang S, Wu Q, Chen H. Cellular metabolic basis of altered immunity in the lungs of patients with COVID-19. Med Microbiol Immunol 2022;211:49-69. [PMID: 35022857 DOI: 10.1007/s00430-021-00727-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 El-Aarag SA, Mahmoud A, ElHefnawi M. Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptome. Int J Biol Macromol 2022;194:770-80. [PMID: 34826456 DOI: 10.1016/j.ijbiomac.2021.11.124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
28 Philips CA, Rela M, Soin AS, Gupta S, Surendran S, Augustine P. Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:947-59. [PMID: 34966658 DOI: 10.14218/JCTH.2021.00228] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Danieli MG, Piga MA, Paladini A, Longhi E, Mezzanotte C, Moroncini G, Shoenfeld Y. Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease. Scand J Immunol 2021;94:e13101. [PMID: 34940980 DOI: 10.1111/sji.13101] [Reference Citation Analysis]
30 Gotelli E, Paolino S, Soldano S, Cutolo M. Vitamin D Immune-Mediated Responses and SARS-CoV-2 Infection: Clinical Implications in COVID-19. Immuno 2022;2:1-12. [DOI: 10.3390/immuno2010001] [Reference Citation Analysis]
31 Sasidharakurup H, Kumar G, Nair B, Diwakar S. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways. OMICS 2021;25:770-81. [PMID: 34807729 DOI: 10.1089/omi.2021.0155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Müller L, Di Benedetto S. How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19. Int J Mol Sci 2021;22:12539. [PMID: 34830421 DOI: 10.3390/ijms222212539] [Reference Citation Analysis]
33 Thapa K, Verma N, Singh TG, Kaur Grewal A, Kanojia N, Rani L. COVID-19-Associated acute respiratory distress syndrome (CARDS): Mechanistic insights on therapeutic intervention and emerging trends. Int Immunopharmacol 2021;101:108328. [PMID: 34768236 DOI: 10.1016/j.intimp.2021.108328] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Al-Karmalawy AA, Soltane R, Abo Elmaaty A, Tantawy MA, Antar SA, Yahya G, Chrouda A, Pashameah RA, Mustafa M, Abu Mraheil M, Mostafa A. Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview. Vaccines (Basel) 2021;9:1317. [PMID: 34835248 DOI: 10.3390/vaccines9111317] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
35 Sukocheva OA, Maksoud R, Beeraka NM, Madhunapantula SV, Sinelnikov M, Nikolenko VN, Neganova ME, Klochkov SG, Amjad Kamal M, Staines DR, Marshall-gradisnik S. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. Journal of Advanced Research 2021. [DOI: 10.1016/j.jare.2021.11.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
36 Zulu MZ, Sureshchandra S, Pinski AN, Doratt B, Shen W, Messaoudi I. Obesity Correlates With Pronounced Aberrant Innate Immune Responses in Hospitalized Aged COVID-19 Patients. Front Immunol 2021;12:760288. [PMID: 34707619 DOI: 10.3389/fimmu.2021.760288] [Reference Citation Analysis]
37 Akamatsu MA, de Castro JT, Takano CY, Ho PL. Off balance: Interferons in COVID-19 lung infections. EBioMedicine 2021;73:103642. [PMID: 34678609 DOI: 10.1016/j.ebiom.2021.103642] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Cham LB, Pahus MH, Grønhøj K, Olesen R, Ngo H, Monrad I, Kjolby M, Tolstrup M, Gunst JD, Søgaard OS. Effect of Age on Innate and Adaptive Immunity in Hospitalized COVID-19 Patients. J Clin Med 2021;10:4798. [PMID: 34682920 DOI: 10.3390/jcm10204798] [Reference Citation Analysis]
39 Castelli EC, de Castro MV, Naslavsky MS, Scliar MO, Silva NSB, Andrade HS, Souza AS, Pereira RN, Castro CFB, Mendes-Junior CT, Meyer D, Nunes K, Matos LRB, Silva MVR, Wang JYT, Esposito J, Coria VR, Bortolin RH, Hirata MH, Magawa JY, Cunha-Neto E, Coelho V, Santos KS, Marin MLC, Kalil J, Mitne-Neto M, Maciel RMB, Passos-Bueno MR, Zatz M. MHC Variants Associated With Symptomatic Versus Asymptomatic SARS-CoV-2 Infection in Highly Exposed Individuals. Front Immunol 2021;12:742881. [PMID: 34650566 DOI: 10.3389/fimmu.2021.742881] [Reference Citation Analysis]
40 Labarrere CA, Kassab GS. Pattern Recognition Proteins: First Line of Defense Against Coronaviruses. Front Immunol 2021;12:652252. [PMID: 34630377 DOI: 10.3389/fimmu.2021.652252] [Reference Citation Analysis]
41 Cintron C, Narasimhan PB, Locks L, Babu S, Sinha P, Rajkumari N, Kaipilyawar V, Bhargava A, Maloomian K, Chandrasekaran P, Verma S, Joseph N, Johnson WE, Wanke C, Horsburgh CR Jr, Ellner JJ, Sarkar S, Salgame P, Lakshminarayanan S, Hochberg NS. Tuberculosis-Learning the Impact of Nutrition (TB LION): protocol for an interventional study to decrease TB risk in household contacts. BMC Infect Dis 2021;21:1058. [PMID: 34641820 DOI: 10.1186/s12879-021-06734-z] [Reference Citation Analysis]
42 Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis VG, Vlachoyiannopoulos PG, Tzioufas AG. COVID-19 Immunobiology: Lessons Learned, New Questions Arise. Front Immunol 2021;12:719023. [PMID: 34512643 DOI: 10.3389/fimmu.2021.719023] [Reference Citation Analysis]
43 Chakrabarty K, Shetty R, Argulwar S, Das D, Ghosh A. Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019. Cytotherapy 2021:S1465-3249(21)00776-3. [PMID: 34656419 DOI: 10.1016/j.jcyt.2021.08.003] [Reference Citation Analysis]
44 de Campos-Mata L, Tejedor Vaquero S, Tachó-Piñot R, Piñero J, Grasset EK, Arrieta Aldea I, Rodrigo Melero N, Carolis C, Horcajada JP, Cerutti A, Villar-García J, Magri G. SARS-CoV-2 sculpts the immune system to induce sustained virus-specific naïve-like and memory B-cell responses. Clin Transl Immunology 2021;10:e1339. [PMID: 34504693 DOI: 10.1002/cti2.1339] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Obuchowska A, Standyło A, Obuchowska K, Kimber-Trojnar Ż, Leszczyńska-Gorzelak B. Cytokine Storms in the Course of COVID-19 and Haemophagocytic Lymphohistiocytosis in Pregnant and Postpartum Women. Biomolecules 2021;11:1202. [PMID: 34439868 DOI: 10.3390/biom11081202] [Reference Citation Analysis]
46 Fischer B, Lindenkamp C, Lichtenberg C, Birschmann I, Knabbe C, Hendig D. Evidence of Long-Lasting Humoral and Cellular Immunity against SARS-CoV-2 Even in Elderly COVID-19 Convalescents Showing a Mild to Moderate Disease Progression. Life (Basel) 2021;11:805. [PMID: 34440549 DOI: 10.3390/life11080805] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Cooper DM, Zulu MZ, Jankeel A, Ibraim IC, Ardo J, Kasper K, Stephens D, Meyer A, Stehli A, Condon C, Londoño ME, Schreiber CM, Lopez NV, Camplain RL, Weiss M, Golden C, Radom-Aizik S, Boden-Albala B, Chau C, Messaoudi I, Ulloa ER. SARS-CoV-2 acquisition and immune pathogenesis among school-aged learners in four diverse schools. Pediatr Res 2021. [PMID: 34304252 DOI: 10.1038/s41390-021-01660-x] [Reference Citation Analysis]
48 Jeyaraman M, Muthu S, Bapat A, Jain R, Sushmitha ES, Gulati A, Channaiah Anudeep T, Dilip SJ, Jha NK, Kumar D, Kesari KK, Ojha S, Dholpuria S, Gupta G, Dureja H, Chellappan DK, Singh SK, Dua K, Jha SK. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon 2021;7:e07635. [PMID: 34312598 DOI: 10.1016/j.heliyon.2021.e07635] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
49 Codd AS, Hanna SJ, Compeer EB, Richter FC, Pring EJ, Gea-mallorquí E, Borsa M, Moon OR, Scourfield DO, Ahern DJ, Almuttaqi H, Alonzi DS, Alrubayyi A, Alsaleh G, Bart VMT, Batchelor V, Bayliss R, Berthold DL, Bezbradica JS, Bharuchq T, Borrmann H, Borsa M, Borst R, Brun J, Burnell S, Capitani L, Cavounidis A, Chapman L, Chauveau A, Cifuentes L, Codd AS, Compeer EB, Coveney C, Cross A, Danielli S, Davies LC, Dendrou CA, Dimonte S, Durairaj RRP, Dustin LB, Dyer A, Fielding C, Fischer F, Gallimore A, Galloway S, Gammage A, Gea-mallorquí E, Godkin A, Hanna SJ, Heuberger C, Hulin-curtis S, Issa F, Jones E, Jones R, Ladell K, Lauder SN, Liddiard K, Ligoxygakis P, Lu F, Maclachlan B, Maleki-toyserkani S, Mann EH, Marzeda AM, Matthews RJ, Mazet JM, Milicic A, Mitchell E, Moon O, Nguyen VD, O'hanlon M, Pavillet CE, Peppa D, Pires A, Pring E, Quastel M, Reed S, Rehwinkel J, Richmond N, Richter FC, Robinson AJB, Rodrigues PRS, Sabberwal P, Sami A, Peres RS, Sattentau Q, Schonfeldova B, Scourfield DO, Selvakumar TA, Shepherd FR, Shorten C, Simon AK, Smith AL, Crespo AT, Tellier M, Thornton E, Uhl LFK, van Grinsven E, Wann AKT, Williams R, Wilson JD, Zhou D, Zhu Z, Gallimore AM, Milicic A; Oxford-Cardiff COVID-19 Literature Consortium. Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology. Oxford Open Immunology 2021;2:iqab016. [DOI: 10.1093/oxfimm/iqab016] [Reference Citation Analysis]
50 Sfera A, Osorio C, Zapata Martín Del Campo CM, Pereida S, Maurer S, Maldonado JC, Kozlakidis Z. Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis. Front Cell Neurosci 2021;15:673217. [PMID: 34248502 DOI: 10.3389/fncel.2021.673217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Lazarevic I, Pravica V, Miljanovic D, Cupic M. Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far? Viruses 2021;13:1192. [PMID: 34206453 DOI: 10.3390/v13071192] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
52 Arjmand B, Alavi-Moghadam S, Parhizkar Roudsari P, Rezaei-Tavirani M, Rahim F, Gilany K, Mohamadi-Jahani F, Adibi H, Larijani B. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions. Front Cell Dev Biol 2021;9:675310. [PMID: 34195193 DOI: 10.3389/fcell.2021.675310] [Reference Citation Analysis]
53 Siemaszko J, Marzec-Przyszlak A, Bogunia-Kubik K. NKG2D Natural Killer Cell Receptor-A Short Description and Potential Clinical Applications. Cells 2021;10:1420. [PMID: 34200375 DOI: 10.3390/cells10061420] [Reference Citation Analysis]
54 Orumaa K, Dunne MR. The role of unconventional T cells in COVID-19. Ir J Med Sci 2021. [PMID: 34050887 DOI: 10.1007/s11845-021-02653-9] [Reference Citation Analysis]
55 Sanz JM, Gómez Lahoz AM, Martín RO. [Role of the immune system in SARS-CoV-2 infection: immunopathology of COVID-19]. Medicine (Madr) 2021;13:1917-31. [PMID: 34075268 DOI: 10.1016/j.med.2021.05.005] [Reference Citation Analysis]
56 Cruz GS, de Jesus AR, Almeida RP, Porto MA. Case Report: Visceral Leishmaniasis and Hemophagocytic Lymphohistiocytosis: Three Clinical Cases, Three Different Pattern. Am J Trop Med Hyg 2021:tpmd201435. [PMID: 34029206 DOI: 10.4269/ajtmh.20-1435] [Reference Citation Analysis]
57 Iovino L, Thur LA, Gnjatic S, Chapuis A, Milano F, Hill JA. Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy. J Immunother Cancer 2021;9:e002392. [PMID: 33986127 DOI: 10.1136/jitc-2021-002392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
58 Deng X, Terunuma H, Nieda M. Immunosurveillance of Cancer and Viral Infections with Regard to Alterations of Human NK Cells Originating from Lifestyle and Aging. Biomedicines 2021;9:557. [PMID: 34067700 DOI: 10.3390/biomedicines9050557] [Reference Citation Analysis]
59 Vulpis E, Giulimondi F, Digiacomo L, Zingoni A, Safavi-Sohi R, Sharifi S, Caracciolo G, Mahmoudi M. The Possible Role of Sex As an Important Factor in Development and Administration of Lipid Nanomedicine-Based COVID-19 Vaccine. Mol Pharm 2021;18:2448-53. [PMID: 33983745 DOI: 10.1021/acs.molpharmaceut.1c00291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Singh B, Mal G, Verma V, Tiwari R, Khan MI, Mohapatra RK, Mitra S, Alyami SA, Emran TB, Dhama K, Moni MA. Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era. Stem Cell Res Ther 2021;12:283. [PMID: 33980321 DOI: 10.1186/s13287-021-02334-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Ahluwalia P, Vaibhav K, Ahluwalia M, Mondal AK, Sahajpal N, Rojiani AM, Kolhe R. Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2. Front Immunol 2021;12:660019. [PMID: 34046033 DOI: 10.3389/fimmu.2021.660019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Andryukov BG, Besednova NN. Older adults: panoramic view on the COVID-19 vaccination. AIMS Public Health 2021;8:388-415. [PMID: 34395690 DOI: 10.3934/publichealth.2021030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Motamedi H, Ari MM, Dashtbin S, Fathollahi M, Hossainpour H, Alvandi A, Moradi J, Abiri R. An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages. Int Immunopharmacol 2021;96:107763. [PMID: 34162141 DOI: 10.1016/j.intimp.2021.107763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Peter AE, Sandeep BV, Rao BG, Kalpana VL. Nanotechnology to the Rescue: Treatment Perspective for the Immune Dysregulation Observed in COVID-19. Front Nanotechnol 2021;3:644023. [DOI: 10.3389/fnano.2021.644023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Delshad M, Tavakolinia N, Pourbagheri-Sigaroodi A, Safaroghli-Azar A, Bagheri N, Bashash D. The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19. Int Immunopharmacol 2021;95:107586. [PMID: 33765611 DOI: 10.1016/j.intimp.2021.107586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
66 Chu R, van Eeden C, Suresh S, Sligl WI, Osman M, Cohen Tervaert JW. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis. Int J Mol Sci 2021;22:2967. [PMID: 33803997 DOI: 10.3390/ijms22062967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Xiong L, Zang X, Feng G, Zhao F, Wang S, Zeng W, Yu K, Zhai Y. Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths. Aging (Albany NY) 2021;13:6289-97. [PMID: 33711813 DOI: 10.18632/aging.202819] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Kang YW, Park S, Lee KJ, Moon D, Kim YM, Lee SW. Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis. Immune Netw 2021;21:e1. [PMID: 33728094 DOI: 10.4110/in.2021.21.e1] [Reference Citation Analysis]
69 Corrao S, Gervasi F, Di Bernardo F, Natoli G, Raspanti M, Catalano N, Argano C. Immunological Characteristics of Non-Intensive Care Hospitalized COVID-19 Patients: A Preliminary Report. J Clin Med 2021;10:849. [PMID: 33669527 DOI: 10.3390/jcm10040849] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Orologas-Stavrou N, Politou M, Rousakis P, Kostopoulos IV, Ntanasis-Stathopoulos I, Jahaj E, Tsiligkeridou E, Gavriatopoulou M, Kastritis E, Kotanidou A, Dimopoulos MA, Tsitsilonis OE, Terpos E. Peripheral Blood Immune Profiling of Convalescent Plasma Donors Reveals Alterations in Specific Immune Subpopulations Even at 2 Months Post SARS-CoV-2 Infection. Viruses 2020;13:E26. [PMID: 33375675 DOI: 10.3390/v13010026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]